(Total Views: 538)
Posted On: 05/05/2020 10:29:31 AM
Post# of 153820
Re: HHIGambler #32185
Quote:
I'm surprised we didn't get a PR about this new pharma agreement. Perhaps they're planning one for tomorrow and Ajinomoto got out ahead of them a day earlier than expected.
They were already working with Ajinimoto (filling services for vials), I would say with AGC biologics production in small amounts.
As per PR it reads:
Ajinimoto: "is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc." and ""Aji Bio-Pharma provides high quality drug product aseptic fill finish services for CytoDyn."
Dr. Pourhassan: "We are extremely pleased to already have been collaborating with Aji Bio-Pharma for the production of leronlimab for other therapeutic indications, allowing us to quickly provide this therapeutic to COVID-19 patients in clinical trials,"
Might in future there will come more out of this partnership, we will see.
(0)
(0)
